Portage Biotech Inc. (PRTG)

[stocktrademan]

$PTGEF recent news/filings

bullish

## source: finance.yahoo.com

Thu, 25 Jun 2015 13:00:00 GMT ~ Portage Completes Non-brokered Private Placement in Two Tranches for a Total Proceeds of US$ 5,155,080

[PR Newswire] - TORONTO, June 25, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (Canadian Securities Exchange: PBT.U , OTC Markets : PTGEF,), is pleased to announce that it has completed its non-brokered private placement raising US$5,155,080 through issuance of approximately 36.8 million common shares at US$0.14 each. The private placement was completed in two tranches, first tranche closed on June 15, 2015 as per our press release of June 16, 2015 and second and final tranche closed on June 24, 2015. The Company is debt free.

read full: http://finance.yahoo.com/news/portage-completes-non-brokered-private-130000198.html
*********************************************************

Tue, 16 Jun 2015 20:52:00 GMT ~ Portage Closes First Tranche of Private Placement

[PR Newswire] - TORONTO, June 16, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), announces that it has raised approximately $3.4 million by closing the first tranche of the non-brokered Private Placement previously announced on May 19, 2015. Pursuant to the terms of the private placement, Portage issued 23,881,214 common shares at a price of US$0.14 per share. All shares issued under private placement are subject to statutory hold periods.

read full: http://finance.yahoo.com/news/portage-closes-first-tranche-private-205200094.html
*********************************************************

Tue, 19 May 2015 13:00:00 GMT ~ Portage announces proposed Private Placement

[PR Newswire] - TORONTO, May 19, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), announces that it intends to conduct a Private Placement to raise up to US$ 5 million for funding its development activities, plan new acquisitions to expand its pipeline and finance clinical activities at Biohaven Pharmaceutical Holding Company Limited, ("Biohaven"). The Company is proposing to complete a non-brokered offering of up to approximately 35.7 million common shares at a price of US$0.14 per Share, for gross proceeds of up to US$5,000,000 ("Private Placement"). Participation in the Private Placement is offered only to "accredited investors" in Canada, the United States and qualified residents in certain other jurisdictions.

read full: http://finance.yahoo.com/news/portage-announces-proposed-private-placement-130000785.html
*********************************************************

Wed, 22 Apr 2015 15:00:00 GMT ~ Portage's Biohaven to begin Phase 1 study in 3Q2015 and readying for Phase 3 study start by 1Q2016

[PR Newswire] - TORONTO, April 22, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that Biohaven Pharmaceutical Holding Company Limited (Biohaven), which Portage holds 54% equity, remains on schedule to initiate a Phase 1 pharmacokinetic and biomarker study with its lead drug development candidate, BHV-0223. Biohaven plans to initiate the trial no later than 3Q2015. Biohaven has entered into an exclusive world-wide agreement with Catalent to provide its Zydis® ODT fast-dissolve formulation for BHV-0223. Without any unforeseen delays, we anticipate a robust completion of the Phase 1 study that will then enable a fully powered registrational Phase 3 study to begin in early in 2016 with results available at the end of 2016 or first part of 2017", stated Kimberly Gentile, Vice-President of Operations for Biohaven.

read full: http://finance.yahoo.com/news/portages-biohaven-begin-phase-1-150000724.html
*********************************************************

Mon, 20 Apr 2015 12:48:00 GMT ~ Portage's CPP Platform Delivers a Peptide Cargo Across Blood Brain Barrier

[PR Newswire] - Portage Pharmaceuticals Ltd. (PPL) Announces that its Proprietary Human-Derived Cell Permeable Peptide (CPP) Platform Delivers a Peptide Cargo Across the Blood Brain Barrier and that this Construct Demonstrates CNS Activity. The permeability of the blood brain barrier (BBB) in mice was studied and was transiently disrupted after endotoxin (LPS) challenge.

read full: http://finance.yahoo.com/news/portages-cpp-platform-delivers-peptide-124800856.html
*********************************************************

$PTGEF charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$PTGEF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/PTGEF/company-info
Ticker: $PTGEF
OTC Market Place: OTC Pink Current
CIK code: 0001095435
Company name: Portage Biotech Inc
Company website: http://www.portagebiotech.com
Incorporated In: Virgin Islands (British)

Business Description: Portage is engaged in researching and developing pharmaceutical and biotech products through to clinical \"proof of concept\" with an initial focus on unmet clinical needs. Following proof of concept, Portage will look to sell or license the products to large pharmaceutical companies for further development and commercialization.Portage is seeking discovery and co-development partners in areas such as cancer, infectious disease, neurology and psychiatry developing novel targeted therapies, stem cell therapy and even older marketed products that have been found to have novel patentable characteristics that bring new value to patients.Portage seeks to work with a wide range of partners, in all phases of development through in-licensing or other types of alliances. The collaboration may include direct funding or investing human capital from our extensive pool of talented scientists and physicians. Specifically Portage will invest sweat equity as well as, or instead of, capital. This internal pool of drug developers, financiers, scientists and physicians will provide unique value-add for our partners including but not limited to mitigating risks, clinical trial design, regulatory expertise and maximizing the rewards. Portage has two operating subsidiaries, portage Pharmaceuticals Limited (\"PPL\") which is wholly owned by Portage and Biohaven Pharmaceutical Holding Company Limited (\"Biohaven\") in which Portage holds 54% equity.PPL has successfully validated a new proprietary cell permeable peptide platform technology derived from human genes. This proprietary platform technology has been shown to efficiently deliver an active pharmacological agent or cargo into a cell without disrupting the cell membrane. The platform has favourable pharmaceutical properties simplifying formulation development for systemic and locally administered conjugates which will allow more rapid development of drug products. PPL has converted its previously filed provisional patent application for this delivery system to an international patent application that includes a variety of structures utilizing cargos that address important areas of medical need.Biohaven?s first drug candidate, BHV-0223, is a reformulated glutamate modulating agent being developed for treatment-resistant mood and anxiety disorders. Biohaven plans to begin a Phase 1 pharmacokinetic and biomarker study by 3Q2015 to confirm optimized drug exposure levels of its novel formulation and fast track its application under Section 505(b)(2) of FDA guidelines.Less >>

$PTGEF share structure

## source: otcmarkets.com

Market Value: $57,477,221 a/o Jun 26, 2015
Shares Outstanding: 205,275,791 a/o Dec 31, 2014
Float: 108,909,253 a/o Dec 31, 2014
Authorized Shares: Unlimited a/o May 24, 2014
Par Value: No Par Value

$PTGEF extra dd links

Company name: Portage Biotech Inc
Company website: http://www.portagebiotech.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PTGEF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PTGEF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PTGEF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/news - http://finance.yahoo.com/q/h?s=PTGEF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PTGEF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PTGEF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PTGEF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Portage+Biotech+Inc&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Portage+Biotech+Inc
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Portage+Biotech+Inc&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.portagebiotech.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.portagebiotech.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.portagebiotech.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PTGEF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001095435&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PTGEF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PTGEF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PTGEF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PTGEF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PTGEF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PTGEF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PTGEF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PTGEF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PTGEF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PTGEF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PTGEF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PTGEF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PTGEF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PTGEF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PTGEF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PTGEF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PTGEF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PTGEF



$PTGEF DD Notes ~ http://www.ddnotesmaker.com/PTGEF